Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

PROCEPT BioRobotics (PRCT) Long-Term Debt Issuances (2024 - 2025)

PROCEPT BioRobotics has reported Long-Term Debt Issuances over the past 2 years, most recently at -$1000.0 for Q3 2025.

Quarterly Long-Term Debt Issuances changed N/A to -$1000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$2.1 million through Sep 2025, changed N/A year-over-year, with the annual reading at $51.2 million for FY2022, N/A changed from the prior year.
Long-Term Debt Issuances was -$1000.0 for Q3 2025 at PROCEPT BioRobotics, up from -$2.1 million in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at -$1000.0 in Q3 2025 and troughed at -$2.1 million in Q4 2024.